| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/18/2013 | US8466286 SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors |
| 06/18/2013 | US8466258 Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis |
| 06/18/2013 | US8465779 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 06/18/2013 | US8465762 Dermal application system for aminolevulinic acid-derivatives |
| 06/18/2013 | US8465753 Combination vaccines against Mycobacterium sp. and methods of using the same |
| 06/18/2013 | US8465725 Process for production of heterodimers of glutamic acid |
| 06/18/2013 | CA2635692C Human anti-il-23 antibodies, compositions, methods and uses |
| 06/13/2013 | WO2013086516A1 Hyperspectral imaging for early detection of alzheimer's disease |
| 06/13/2013 | WO2013086457A1 Caged compound delivery and related compositions, methods and systems |
| 06/13/2013 | WO2013085718A1 Multifunctional small molecules |
| 06/13/2013 | WO2013084204A1 Mri-visible hydrophobic copolymer |
| 06/13/2013 | WO2013083535A1 Composition comprising acetic anhydride and a gadolinium complex, and method for the use in hyperpolarisation mri analysis |
| 06/13/2013 | WO2013056132A3 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof |
| 06/13/2013 | WO2013054126A3 Nanocolloids for local temperature monitoring |
| 06/13/2013 | US20130149539 Tuned multifunctional magnetic nanoparticles for biomedicine |
| 06/13/2013 | US20130149252 Switching fluorescent nanoparticle probe and fluorescent particle imaging method using same |
| 06/13/2013 | US20130149251 Optical sensor conjugates for detecting reactive oxygen and/or reactive nitrogen species in vivo |
| 06/13/2013 | US20130149247 Vivo tumor targeting and spectroscopic detection with surface-enhanced raman nanoparticle tags |
| 06/13/2013 | US20130149245 Novel Peptides and Uses Thereof |
| 06/13/2013 | US20130149241 Peptide radiotracer compositions |
| 06/12/2013 | EP2600903A2 Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same |
| 06/12/2013 | EP2600902A1 Radiopaque shape memory polymers for medical devices |
| 06/12/2013 | EP2600855A2 Combination therapy for the treatment of prostate carcinoma |
| 06/12/2013 | CN103154272A Methods and kits for predicting the risk of diabetes associated complications using genetic markers and arrays |
| 06/12/2013 | CN103153969A Mri contrast agents comprising gd-complexes |
| 06/12/2013 | CN103153927A Fused cyclooctyne compounds and their use in metal-free click reactions |
| 06/12/2013 | CN103153348A Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same |
| 06/12/2013 | CN103146804A Specificity probe zymolyte of glucuronic acid transferase UGT1A1 and application |
| 06/12/2013 | CN103146220A Symmetric pentamethyl cyanine dye and application thereof to molecular imaging |
| 06/12/2013 | CN103145824A Mutant cryptochromel 1 and transgenic pig of mutant cryptochromel 1 |
| 06/12/2013 | CN103143043A Preparation method of Fe3O4/Au composite nanoparticles |
| 06/12/2013 | CN103143042A Superpara magnetism polymeric microsphere magnetic resonance imaging (MRI) contrast agent and preparation method thereof |
| 06/12/2013 | CN103143041A Preparation method of targeted MRI (magnetic resonance imaging) contrast medium based on folic acid modified iron oxide nanoparticles |
| 06/12/2013 | CN103143040A Preparation method of target beta amyloid protein photographic developer |
| 06/12/2013 | CN103143039A Ointment for haemorrhoid physical sign |
| 06/12/2013 | CN103143038A High-sensitivity safety evaluation method for Chinese medicine injection |
| 06/12/2013 | CN103143037A Method for synthesizing rare earth metal compound nano cluster and application thereof |
| 06/12/2013 | CN103143036A Method for analyzing Parkinson disease therapeutic effect |
| 06/12/2013 | CN103143035A Application of heteroatoms doped aqueous carbon quantum dot in preparation of photo-sensitizers for fluorescent imaging marking and photodynamic therapy (PDT) |
| 06/12/2013 | CN103143034A Recombinant vaccine against bluetongue virus |
| 06/12/2013 | CN103143013A Photosensitive medicinal preparation containing amino poly-carboxylic acid modification tetraphenylporphyrin compound and purpose thereof |
| 06/12/2013 | CN102657612B GDNF-carrying microbubble preparation and method for making the same |
| 06/12/2013 | CN102526766B Naphthdianthrone compound and application of salt thereof in preparing developer of biliary tract and gall stones |
| 06/12/2013 | CN102379685B Automatic pain analysis system |
| 06/12/2013 | CN102372307B Method for preparing magnetic hollow cluster from ferroferric oxide nano crystals by one step |
| 06/12/2013 | CN102286432B Method for building animal model of coxsachie virus 16 (CA16) infection and kit |
| 06/12/2013 | CN102228442B Star-like macromolecule nanometer microsphere and preparation method and application thereof |
| 06/12/2013 | CN102188721B Liquid preparation of gastrointestinal series agent for gastrointestinal series, and preparation method thereof |
| 06/12/2013 | CN101378784B Method to produce hyperpolarised carboxylates |
| 06/11/2013 | US8463012 System for comparison of medical images |
| 06/11/2013 | US8461119 Peptides, peptidomimetics; promoting programmed cell death; neural regeneration |
| 06/11/2013 | US8460640 Narcotic drug formulations with decreased abuse potential |
| 06/11/2013 | CA2533542C Method of determining sperm capacitation |
| 06/11/2013 | CA2491484C Scanning suspension comprising a particle with a diameter of at least 1 micrometer |
| 06/11/2013 | CA2469336C Guanidinium transport reagents and conjugates |
| 06/11/2013 | CA2442839C Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 06/06/2013 | WO2013082286A1 Peptide-mediated delivery of active agents across the blood-brain barrier |
| 06/06/2013 | WO2013049521A3 Light-enabled drug delivery |
| 06/06/2013 | WO2013019917A3 Permanent attachment of ammonium and guanidine-based antimicrobials to surfaces containing c-h functionality |
| 06/06/2013 | US20130144159 Medical-surgical devices |
| 06/06/2013 | US20130143970 Medicinal preparation particularly for the treatment of slipped discs hernias |
| 06/06/2013 | US20130142878 Peptide particle formulation |
| 06/06/2013 | US20130142735 In Vivo Mitochondrial Labeling Using Positively-CHarged Nitroxide Enhanced and Gadolinum Chelate Enhanced Magnetic Resonance Imaging |
| 06/06/2013 | US20130142734 Targeted delivery systems for diagnostic applications |
| 06/06/2013 | US20130142733 Multifunctional degradable nanoparticles with control over size and functionalities |
| 06/06/2013 | US20130142732 Recombinant fluorescent nanoparticles |
| 06/06/2013 | CA2857287A1 Peptide-mediated delivery of active agents across the blood-brain barrier |
| 06/06/2013 | CA2855566A1 Multivalent antibody complexes targeting igf-1r show potent toxicity against solid tumors |
| 06/06/2013 | CA2854194A1 Mmp-targeted therapeutic and/or diagnostic nanocarriers |
| 06/05/2013 | EP2599777A1 Process for the preparation of Calcobutrol |
| 06/05/2013 | EP2599497A2 Porphyrazine-chemotherapeutic agents conjugates |
| 06/05/2013 | EP2598174A1 Measurement method for determining an organ function |
| 06/05/2013 | EP2598169A1 An antigen specific ultrasound contrast medium, a process for the preparation thereof and its uses |
| 06/05/2013 | EP2598156A1 Formulations containing extracts of echinacea angustifolia and zingiber officinale which are useful in reducing inflammation and peripheral pain |
| 06/05/2013 | DE202006021184U1 Wässrige Methacetin-Lösung Aqueous solution methacetin |
| 06/05/2013 | CN1798545B Method for improving stability and shelf-life of liposome complexes |
| 06/05/2013 | CN103140241A An antigen specific ultrasound contrast medium, a process for the preparation thereof and its uses |
| 06/05/2013 | CN103131005A Amino acid block copolymer and preparation method and compound thereof |
| 06/05/2013 | CN103127530A Application of targeted beta amyloid protein photographic developer |
| 06/05/2013 | CN103127529A Traditional Chinese medicine capsules used for removing intragastric gas of gastroenterology patient |
| 06/05/2013 | CN102698296B Gastrointestinal series agent |
| 06/05/2013 | CN102614531B Multi-core non-ion type magnetic resonance imaging contrast agent using diacetyl benzene or triacetyl benzene as linker |
| 06/05/2013 | CN102552941B Two-nuclear magnetic resonance imaging contrast agent taking 2,5-dimethylpyrazine as connector and preparation method of two-nuclear magnetic resonance imaging contrast agent |
| 06/05/2013 | CN102198278B Rhesus monkey retinal degeneration model, and drug screening method thereof |
| 06/04/2013 | US8454964 Three dimensionally crosslinked agarose bead with grass pollen covalently bound; immunotherapy, vaccines, diagnosis |
| 05/30/2013 | WO2013076305A1 Formulation of solid nano-sized particles in a gel-forming system |
| 05/30/2013 | WO2013076159A1 Biarsenical nanoparticles for in vivo labeling |
| 05/30/2013 | WO2013075233A1 Method for treating brain cancer |
| 05/30/2013 | US20130136699 Diagnostic reagents |
| 05/30/2013 | US20130136698 Integrated photoactive agents and uses thereof |
| 05/30/2013 | US20130136693 Crystal Forms of 2--Adenosine |
| 05/29/2013 | CN1956738B Antibodies to MAdCAM |
| 05/29/2013 | CN103122154A Organic near-infrared two-photon fluorescent dye |
| 05/29/2013 | CN103121705A Preparation method of CuS nanoparticles, product and application thereof |
| 05/29/2013 | CN103120799A Gas-filled microvesicles composition for contrast imaging |
| 05/29/2013 | CN103120797A Nano-drug carrier for reductive response, nano-drug particle, nano-drug particle preparation and preparation methods thereof |
| 05/29/2013 | CN102406949B Target tracing multi-mode diagnostic nano imaging medicine |
| 05/29/2013 | CN102397564B Tumor-targeted diagnosis nuclear magnetic resonance contrast agent and preparation method thereof |
| 05/29/2013 | CN102267999B Flumazenil compound and preparation method thereof |
| 05/29/2013 | CN102167728B 改进的胃泌素释放肽化合物 Improved gastrin-releasing peptide compounds |